Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...

A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, ...

The coronavirus will never disappear, Moderna CEO Stephan Bancel said during a panel earlier this week. “We are going to live with this virus, we think, forever,” he said. Separately ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Explore the truth behind false claims that Moderna's CEO confessed to creating a COVID-19 vaccine before the pandemic, and the context of his remarks on vaccine production.

With COVID-19 revenues now shrinking fast, Moderna chief executive Stéphane Bancel has taken the decision ... Jonah Comstock met with Rick Stewart, CEO of Achieve Life Sciences.

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

Moderna lost more than 20% of its value ... stressing savings as key to its goal of balancing cash flow by 2028. Ahead of CEO Stéphane Bancel’s address at the JP Morgan Healthcare Conference ...

hospitalization,” said Stéphane Bancel, CEO of Moderna, in a statement last fall. “By advancing our investigational norovirus vaccine into a pivotal Phase 3 trial, we are one step closer to ...

It expects to end 2025 with a cash balance of $6 billion. Moderna CEO Stephane Bancel commented, "In 2024, we achieved $3.0 - 3.1 billion in product sales, approval of our RSV vaccine and ...